These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25164785)

  • 1. The consequences of genetic and pharmacologic reduction in sphingolipid synthesis.
    Schiffmann R
    J Inherit Metab Dis; 2015 Jan; 38(1):77-84. PubMed ID: 25164785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingolipid synthetic pathways are major regulators of lipid homeostasis.
    Worgall TS
    Adv Exp Med Biol; 2011; 721():139-48. PubMed ID: 21910087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-wide CRISPR/Cas9 screen reveals that the aryl hydrocarbon receptor stimulates sphingolipid levels.
    Majumder S; Kono M; Lee YT; Byrnes C; Li C; Tuymetova G; Proia RL
    J Biol Chem; 2020 Mar; 295(13):4341-4349. PubMed ID: 32029474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of l-serine and sphingolipid synthesis in brain development and neuronal survival.
    Hirabayashi Y; Furuya S
    Prog Lipid Res; 2008 May; 47(3):188-203. PubMed ID: 18319065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of
    Sellin J; Schulze H; Paradis M; Gosejacob D; Papan C; Shevchenko A; Psathaki OE; Paululat A; Thielisch M; Sandhoff K; Hoch M
    Dis Model Mech; 2017 Jun; 10(6):737-750. PubMed ID: 28389479
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Alexaki A; Clarke BA; Gavrilova O; Ma Y; Zhu H; Ma X; Xu L; Tuymetova G; Larman BC; Allende ML; Dunn TM; Proia RL
    J Biol Chem; 2017 Mar; 292(9):3929-3939. PubMed ID: 28100772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The
    Clarke BA; Majumder S; Zhu H; Lee YT; Kono M; Li C; Khanna C; Blain H; Schwartz R; Huso VL; Byrnes C; Tuymetova G; Dunn TM; Allende ML; Proia RL
    Elife; 2019 Dec; 8():. PubMed ID: 31880535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. My journey into the world of sphingolipids and sphingolipidoses.
    Sandhoff K
    Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(10):554-82. PubMed ID: 23229750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A view on sphingolipids and disease.
    Kolter T
    Chem Phys Lipids; 2011 Sep; 164(6):590-606. PubMed ID: 21570958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances and novel treatments for sphingolipidoses.
    Arenz C
    Future Med Chem; 2017 Sep; 9(14):1687-1700. PubMed ID: 28857617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic defects in the sphingolipid degradation pathway and their effects on microglia in neurodegenerative disease.
    Allende ML; Zhu H; Kono M; Hoachlander-Hobby LE; Huso VL; Proia RL
    Cell Signal; 2021 Feb; 78():109879. PubMed ID: 33296739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties.
    Russo SB; Tidhar R; Futerman AH; Cowart LA
    J Biol Chem; 2013 May; 288(19):13397-409. PubMed ID: 23530041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
    Dany M; Elston D
    J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.
    Holleran WM; Man MQ; Gao WN; Menon GK; Elias PM; Feingold KR
    J Clin Invest; 1991 Oct; 88(4):1338-45. PubMed ID: 1918384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal sphingolipidoses: Membrane lipids and sphingolipid activator proteins regulate lysosomal sphingolipid catabolism.
    Sandhoff K
    Biochimie; 2016 Nov; 130():146-151. PubMed ID: 27157270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I - A link to metabolic control.
    Hornemann T; Alecu I; Hagenbuch N; Zhakupova A; Cremonesi A; Gautschi M; Jung HH; Meienberg F; Bilz S; Christ E; Baumgartner MR; Hochuli M
    Mol Genet Metab; 2018 Sep; 125(1-2):73-78. PubMed ID: 30037504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipids and neuronal degeneration in lysosomal storage disorders.
    Grassi S; Chiricozzi E; Mauri L; Sonnino S; Prinetti A
    J Neurochem; 2019 Mar; 148(5):600-611. PubMed ID: 29959861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ORMDL/serine palmitoyltransferase stoichiometry determines effects of ORMDL3 expression on sphingolipid biosynthesis.
    Siow D; Sunkara M; Dunn TM; Morris AJ; Wattenberg B
    J Lipid Res; 2015 Apr; 56(4):898-908. PubMed ID: 25691431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements.
    Holleran WM; Gao WN; Feingold KR; Elias PM
    Arch Dermatol Res; 1995; 287(3-4):254-8. PubMed ID: 7598529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.